Structure-based virtual screening of CYP1A1 inhibitors: towards rapid tier-one assessment of potential developmental toxicants
Open Access
- 28 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Archives of Toxicology
- Vol. 95 (9), 3031-3048
- https://doi.org/10.1007/s00204-021-03111-2
Abstract
Cytochrome P450 1A1 (CYP1A1) metabolizes estrogens, melatonin, and other key endogenous signaling molecules critical for embryonic/fetal development. The enzyme has increasing expression during pregnancy, and its inhibition or knockout increases embryonic/fetal lethality and/or developmental problems. Here, we present a virtual screening model for CYP1A1 inhibitors based on the orthosteric and predicted allosteric sites of the enzyme. Using 1001 reference compounds with CYP1A1 activity data, we optimized the decision thresholds of our model and classified the training compounds with 68.3% balanced accuracy (91.0% sensitivity and 45.7% specificity). We applied our final model to 11 known CYP1A1 orthosteric binders and related compounds, and found that our ranking of the known orthosteric binders generally agrees with the relative activity of CYP1A1 in metabolizing these compounds. We also applied the model to 22 new test compounds with unknown/unclear CYP1A1 inhibitory activity, and predicted 16 of them are CYP1A1 inhibitors. The CYP1A1 potency and modes of inhibition of these 22 compounds were experimentally determined. We confirmed that most predicted inhibitors, including drugs contraindicated during pregnancy (amiodarone, bicalutamide, cyproterone acetate, ketoconazole, and tamoxifen) and environmental agents suspected to be endocrine disruptors (bisphenol A, diethyl and dibutyl phthalates, and zearalenone), are indeed potent inhibitors of CYP1A1. Our results suggest that virtual screening may be used as a rapid tier-one method to screen for potential CYP1A1 inhibitors, and flag them out for further experimental evaluations.Keywords
Funding Information
- BMRC-EDB (H18/01/a0/B14)
This publication has 73 references indexed in Scilit:
- Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic Metabolism*Online Journal of Public Health Informatics, 2013
- Identification of cavities on protein surface using multiple computational approaches for drug binding site predictionBioinformatics, 2011
- Uncovering the Role of Hydrophobic Residues in Cytochrome P450−Cytochrome P450 Reductase InteractionsBiochemistry, 2011
- The interaction of microsomal cytochrome P450 2B4 with its redox partners, cytochrome P450 reductase and cytochrome b5Archives of Biochemistry and Biophysics, 2011
- Metabolic oxidation regulates embryonic stem cell differentiationNature Chemical Biology, 2010
- Molecular Docking Screens Using Comparative Models of ProteinsJournal of Chemical Information and Modeling, 2009
- Phenotype of theCyp1a1/1a2/1b1(-/-) Triple-Knockout MouseMolecular Pharmacology, 2008
- Structural basis for ligand promiscuity in cytochrome P450 3A4Proceedings of the National Academy of Sciences of the United States of America, 2006
- Down-Regulation of Murine Cyp1a-1 in Mouse Hepatoma Hepa-1c1c7 Cells by Bisphenol ABiochemical and Biophysical Research Communications, 2000
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974